OBJECTIVE: Barrett's oesophagus is a premalignant disease associated with oesophageal adenocarcinoma. The major goal of this study was to determine the mechanism responsible for bile acid-induced alteration in intracellular pH (pH(i)) and its effect on DNA damage in cells derived from normal oesophagus (HET1A) or Barrett's oesophagus (CP-A). DESIGN: Cells were exposed to bile acid cocktail (BA) and/or acid in the presence/absence of inhibitors of nitric oxide synthase (NOS) or sodium-hydrogen exchanger (NHE). Nitric oxide (NO), pH(i) and DNA damage were measured by fluorescent imaging and comet assay. Expression of NHE1 and NOS in cultured cells and biopsies from Barrett's oesophagus or normal squamous epithelium was determined by RT-PCR, immunoblotting or immunohistochemistry. RESULTS: A dose dependent decrease in pH(i) was observed in CP-A cells exposed to BA. This effect of BA is the consequence of NOS activation and increased NO production, which leads to NHE inhibition. Exposure of oesophageal cells to acid in combination with BA synergistically decreased pH(i). The decrease was more pronounced in CP-A cells and resulted in >2-fold increase in DNA damage compared to acid treatment alone. Examination of biopsies and cell lines revealed robust expression of NHE1 in Barrett's oesophagus but an absence of NHE1 in normal epithelium. CONCLUSIONS: The results of this study identify a new mechanism of bile acid-induced DNA damage. We found that bile acids present in the refluxate activate immediately all three isoforms of NOS, which leads to an increased NO production and NHE inhibition. This consequently results in increased intracellular acidification and DNA damage, which may lead to mutations and cancer progression. Therefore, we propose that in addition to gastric reflux, bile reflux should be controlled in patients with Barrett's oesophagus.
OBJECTIVE:Barrett's oesophagus is a premalignant disease associated with oesophageal adenocarcinoma. The major goal of this study was to determine the mechanism responsible for bile acid-induced alteration in intracellular pH (pH(i)) and its effect on DNA damage in cells derived from normal oesophagus (HET1A) or Barrett's oesophagus (CP-A). DESIGN: Cells were exposed to bile acid cocktail (BA) and/or acid in the presence/absence of inhibitors of nitric oxide synthase (NOS) or sodium-hydrogen exchanger (NHE). Nitric oxide (NO), pH(i) and DNA damage were measured by fluorescent imaging and comet assay. Expression of NHE1 and NOS in cultured cells and biopsies from Barrett's oesophagus or normal squamous epithelium was determined by RT-PCR, immunoblotting or immunohistochemistry. RESULTS: A dose dependent decrease in pH(i) was observed in CP-A cells exposed to BA. This effect of BA is the consequence of NOS activation and increased NO production, which leads to NHE inhibition. Exposure of oesophageal cells to acid in combination with BA synergistically decreased pH(i). The decrease was more pronounced in CP-A cells and resulted in >2-fold increase in DNA damage compared to acid treatment alone. Examination of biopsies and cell lines revealed robust expression of NHE1 in Barrett's oesophagus but an absence of NHE1 in normal epithelium. CONCLUSIONS: The results of this study identify a new mechanism of bile acid-induced DNA damage. We found that bile acids present in the refluxate activate immediately all three isoforms of NOS, which leads to an increased NO production and NHE inhibition. This consequently results in increased intracellular acidification and DNA damage, which may lead to mutations and cancer progression. Therefore, we propose that in addition to gastric reflux, bile reflux should be controlled in patients with Barrett's oesophagus.
Authors: Gareth J S Jenkins; Francis R D'Souza; Sinan H Suzen; Zak S Eltahir; Sally A James; James M Parry; Paul A Griffiths; John N Baxter Journal: Carcinogenesis Date: 2006-08-11 Impact factor: 4.944
Authors: Linda A Feagins; Hui-Ying Zhang; Kathy Hormi-Carver; Mizael H Quinones; Deena Thomas; Xi Zhang; Lance S Terada; Stuart J Spechler; Ruben D Ramirez; Rhonda F Souza Journal: Am J Gastroenterol Date: 2007-01 Impact factor: 10.864
Authors: Alan Prem Kumar; Ai Li Quake; Michelle Ker Xing Chang; Ting Zhou; Kelly Swee Ying Lim; Rajeev Singh; Robert Edwin Hewitt; Manuel Salto-Tellez; Shazib Pervaiz; Marie-Véronique Clément Journal: Cancer Res Date: 2009-11-03 Impact factor: 12.701
Authors: George S Watts; Nhan L Tran; Michael E Berens; Achyut K Bhattacharyya; Mark A Nelson; Elizabeth A Montgomery; Richard E Sampliner Journal: Int J Cancer Date: 2007-11-15 Impact factor: 7.396
Authors: Cedric Roudebush; Alma Catala-Valentin; Thomas Andl; Gregoire F Le Bras; Claudia D Andl Journal: Cytokine Date: 2019-07-29 Impact factor: 3.861
Authors: Jeffrey Molendijk; Cathryn M Kolka; Henry Cairns; Sandra Brosda; Ahmed Mohamed; Alok K Shah; Ian Brown; Mark P Hodson; Thomas Hennessy; Guanghao Liu; Thomas Stoll; Renee S Richards; Michael Gartside; Kalpana Patel; Nicholas J Clemons; Wayne A Phillips; Andrew Barbour; Johan A Westerhuis; Michelle M Hill Journal: Clin Transl Med Date: 2022-05
Authors: Eva Kunstár; Péter Hegyi; Zoltán Rakonczay; Klaudia Farkas; Ferenc Nagy; Tibor Wittmann; Tamás Molnár Journal: Front Physiol Date: 2011-08-17 Impact factor: 4.566
Authors: Aaron Goldman; HwuDauRw Chen; Mohammad R Khan; Heather Roesly; Kimberly A Hill; Mohammad Shahidullah; Amritlal Mandal; Nicholas A Delamere; Katerina Dvorak Journal: PLoS One Date: 2011-08-22 Impact factor: 3.240